Corbus Pharmaceuticals Holdings (CRBP) Capital Expenditures (2014 - 2024)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Capital Expenditures came in at $1000.0 in Q2 2024, up 100.47% quarter-over-quarter from -$213000.0 in Q1 2024.
Corbus Pharmaceuticals Holdings (CRBP) Capital Expenditures (2014 - 2024) Analysis & Trends
Corbus Pharmaceuticals Holdings' Capital Expenditures history runs 11 years deep, the most recent figure standing at $1000.0 for Q2 2024.
- On a quarterly basis, Capital Expenditures changed N/A year-over-year to $1000.0 in Q2 2024; TTM through Mar 2025 was $1000.0, a 100.64% increase from a year earlier, with the FY2024 full-year figure at -$212000.0, down 471.93% from the prior year.
- Capital Expenditures climbed to $1000.0 in Q2 2024 per CRBP's latest filing, from -$213000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $463605.0 in Q1 2020 and bottomed at -$213000.0 in Q1 2024.
- The 5-year median for Capital Expenditures is $14811.5 (2020), against an average of $39711.2.
- Biggest YoY gain for Capital Expenditures was 567.45% in 2020; the steepest drop was 104.03% in 2020.
- Year by year, Capital Expenditures stood at -$52086.0 in 2020, then soared by 204.0% to $54172.0 in 2021, then sank by 75.17% to $13449.0 in 2022, then dropped by 18.21% to $11000.0 in 2023, then plunged by 90.91% to $1000.0 in 2024.
- Per Business Quant, the three latest CRBP Capital Expenditures figures stand at $1000.0 (Q2 2024), -$213000.0 (Q1 2024), and $11000.0 (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -213,000.00 |
| Mar 31, 2024 | -213,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | 46,000.00 |
| Sep 30, 2023 | 46,000.00 |
| Mar 31, 2022 | 13,449.00 |
| Mar 31, 2022 | 13,449.00 |
| Dec 31, 2021 | 54,172.00 |
| Dec 31, 2021 | 54,172.00 |
| Dec 31, 2020 | -52,086.00 |
| Dec 31, 2020 | -52,086.00 |
| Sep 30, 2020 | 56,798.00 |
| Sep 30, 2020 | 56,798.00 |
| Jun 30, 2020 | 16,174.00 |
| Jun 30, 2020 | 16,174.00 |
| Mar 31, 2020 | 463,605.00 |
| Mar 31, 2020 | 463,605.00 |